Apotex International is the worldwide sales and marketing division of Apotex Inc. for products sold outside of Canada and the United States. Representing the largest Canadian -owned pharmaceutical Company, Apotex International has established working relationships in more than 115 countries worldwide through a commitment to manufacturing excellence, and a first to market product development strategy for bio-equivalent generics.

Through an ever expanding network of wholly owned subsidiaries, distributor and contract supply agreements, Apotex International is poised to take it’s place amongst the world’s leading bio-equivalent generic companies.

For more information, please contact us.